ziresovir
未知生产厂商
Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).
Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).
用于儿童呼吸道合胞病毒（RSV）引起的上呼吸道感染。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
